Clinical Trials Browser

Phase 2 × GSK2141795 × 30 days × Clear all

NCT01979523 2026-03-19

Trametinib With or Without GSK2141795 in Treating Patients With Metastatic Uveal Melanoma

Phase 2 Active not recruiting

42 enrolled 13 charts

Uveal Melanoma